Diflomotecan. Ipsen

IDrugs. 2004 Mar;7(3):257-63.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Camptothecin / analogs & derivatives*
  • Camptothecin / chemistry
  • Camptothecin / pharmacology
  • Camptothecin / therapeutic use*
  • Clinical Trials as Topic / statistics & numerical data
  • DNA Topoisomerases, Type I / metabolism
  • Drugs, Investigational / chemistry
  • Drugs, Investigational / pharmacology
  • Drugs, Investigational / therapeutic use*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / enzymology
  • Topoisomerase I Inhibitors

Substances

  • Antineoplastic Agents
  • Drugs, Investigational
  • Enzyme Inhibitors
  • Topoisomerase I Inhibitors
  • DNA Topoisomerases, Type I
  • diflomotecan
  • Camptothecin